1. Home
  2. EVOK vs ABTS Comparison

EVOK vs ABTS Comparison

Compare EVOK & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • ABTS
  • Stock Information
  • Founded
  • EVOK 2007
  • ABTS 2010
  • Country
  • EVOK United States
  • ABTS Hong Kong
  • Employees
  • EVOK N/A
  • ABTS N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • ABTS Computer Software: Programming Data Processing
  • Sector
  • EVOK Health Care
  • ABTS Technology
  • Exchange
  • EVOK Nasdaq
  • ABTS Nasdaq
  • Market Cap
  • EVOK 4.2M
  • ABTS 4.6M
  • IPO Year
  • EVOK 2013
  • ABTS N/A
  • Fundamental
  • Price
  • EVOK $2.95
  • ABTS $4.77
  • Analyst Decision
  • EVOK
  • ABTS
  • Analyst Count
  • EVOK 0
  • ABTS 0
  • Target Price
  • EVOK N/A
  • ABTS N/A
  • AVG Volume (30 Days)
  • EVOK 14.3K
  • ABTS 397.7K
  • Earning Date
  • EVOK 05-13-2025
  • ABTS 04-30-2025
  • Dividend Yield
  • EVOK N/A
  • ABTS N/A
  • EPS Growth
  • EVOK N/A
  • ABTS N/A
  • EPS
  • EVOK N/A
  • ABTS N/A
  • Revenue
  • EVOK $11,594,083.00
  • ABTS $6,711,225.00
  • Revenue This Year
  • EVOK $57.82
  • ABTS N/A
  • Revenue Next Year
  • EVOK $59.12
  • ABTS N/A
  • P/E Ratio
  • EVOK N/A
  • ABTS N/A
  • Revenue Growth
  • EVOK 89.89
  • ABTS 299.11
  • 52 Week Low
  • EVOK $1.94
  • ABTS $1.35
  • 52 Week High
  • EVOK $12.32
  • ABTS $14.10
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 38.86
  • ABTS 59.34
  • Support Level
  • EVOK $3.33
  • ABTS $3.75
  • Resistance Level
  • EVOK $3.66
  • ABTS $4.40
  • Average True Range (ATR)
  • EVOK 0.29
  • ABTS 0.53
  • MACD
  • EVOK -0.06
  • ABTS 0.01
  • Stochastic Oscillator
  • EVOK 2.99
  • ABTS 100.00

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About ABTS Abits Group Inc

Abits Group Inc is a digital data center operator with bitcoin self-mining operations.

Share on Social Networks: